Lion TCR Pte. Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Singapore Singapore (2015)

Organization Overview

First Clinical Trial
2018
NCT03634683
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Lion TCR Pte. Ltd.